These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3588642)

  • 21. Microbial contamination of a vitamin A formulation, prepared in local pharmacies, and its preservation against yeasts and moulds.
    van Doorne H; Scheffers WA; Hadiutomo M; van den Bosch E
    Antonie Van Leeuwenhoek; 1984; 50(4):405-16. PubMed ID: 6524914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The use of preservatives in skin preparations].
    Van Ooteghem M
    Pharmazie; 1984 Sep; 39(9):621-5. PubMed ID: 6504999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bacterial adaptation and resistance to antiseptics, disinfectants and preservatives is not a new phenomenon.
    Russell AD
    J Hosp Infect; 2004 Jun; 57(2):97-104. PubMed ID: 15183238
    [No Abstract]   [Full Text] [Related]  

  • 24. [Usefulness of chemical preservatives for semi-quantitative urine culture].
    Wachtel D; Metzel D; Knauer H; Exner G; Mücke H
    Z Gesamte Inn Med; 1974 Sep; 29(17):709-12. PubMed ID: 4217053
    [No Abstract]   [Full Text] [Related]  

  • 25. Hypersensitivity to methylhydroxybenzoate: a case for additive labelling of pharmaceuticals.
    Batty KT
    Med J Aust; 1986 Jan; 144(2):107-8. PubMed ID: 3941634
    [No Abstract]   [Full Text] [Related]  

  • 26. Evaluating preservative efficacy by challenge testing during the development stage of pharmaceutical products.
    Moore KE
    J Appl Bacteriol; 1978 Jun; 44(3):Sxliii-Slv. PubMed ID: 353021
    [No Abstract]   [Full Text] [Related]  

  • 27. [Low-level challenge test for the examination of the microbiological susceptibility, during the period of use, of liquid and semi-solid dosage forms in multiple-dose containers (author's transl)].
    Urban S; Hecker W; Schiller I
    Zentralbl Bakteriol Mikrobiol Hyg B; 1981; 172(6):478-84. PubMed ID: 7257652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Test of preservation on decoction of medicinal herbs].
    Ge YX
    Zhong Yao Tong Bao; 1982; 7(6):20-1. PubMed ID: 6218915
    [No Abstract]   [Full Text] [Related]  

  • 29. [Nisin, a potential preservative for topical preparations].
    Valenta C; Bernkop-Schnürch A; Teltscher C
    Pharmazie; 1996 Feb; 51(2):119-22. PubMed ID: 8720808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [On the stability of ointments containing tetracycline hydrochloride].
    Stavri N; Gafiţeanu E; Pastia A
    Rev Med Chir Soc Med Nat Iasi; 1972; 76(2):347-51. PubMed ID: 5069928
    [No Abstract]   [Full Text] [Related]  

  • 31. [Study of several preservatives. Control of their antimicrobial effectiveness in an emulsified preparation].
    Desvignes A; Bernard J; Sébastien F; Frottier M
    Ann Pharm Fr; 1974 Jan; 32(1):37-52. PubMed ID: 4440998
    [No Abstract]   [Full Text] [Related]  

  • 32. [Mixtures for the preservation of gamasid ticks].
    Evseeva VE
    Med Parazitol (Mosk); 1974; 43(5):607-8. PubMed ID: 4456186
    [No Abstract]   [Full Text] [Related]  

  • 33. The testing of preservatives for ophthalmic preparations [proceedings].
    Hobbs RJ; Sasi SA; Davies DJ
    J Pharm Pharmacol; 1979 Dec; 31 Suppl():58P. PubMed ID: 42734
    [No Abstract]   [Full Text] [Related]  

  • 34. [Microbiological evaluation of sterilization of selected pharmaceutical raw materials with ethylene oxide].
    Woźniak-Parnowska W; Najer A; Sobiczewska M
    Acta Pol Pharm; 1980; 37(1):113-9. PubMed ID: 7395545
    [No Abstract]   [Full Text] [Related]  

  • 35. [Comparative characteristics of blood prepared with No. 12 and 76 preservatives].
    Oldurova SV; Suvorova LA; Sukhova AG; Golubeva VL; Manueva GN
    Probl Gematol Pereliv Krovi; 1975 Jan; 20(1):40-3. PubMed ID: 1110962
    [No Abstract]   [Full Text] [Related]  

  • 36. [Laboratory-clinical substantiation of permissibility of blood preparation on preservatives without levomycetin].
    Petrov MM; Fedorovskaia EA; Kushko OV; Babiĭ ZN; Petrushov VN
    Probl Gematol Pereliv Krovi; 1978 May; 23(5):55-7. PubMed ID: 674150
    [No Abstract]   [Full Text] [Related]  

  • 37. Sterility testing of immunological products: comparative efficacy of media and effect of preservatives.
    Thornton DH; Maley AD; Frerichs GN
    J Biol Stand; 1987 Apr; 15(2):117-26. PubMed ID: 3597447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Preservative substances in local anesthetics].
    Perotti R; Osenga G; Debernardi C
    Minerva Stomatol; 1985; 34(4):707-12. PubMed ID: 3930936
    [No Abstract]   [Full Text] [Related]  

  • 39. Inclusion of antimicrobial agents as preservatives in cosmetic products.
    Duke AM
    J Appl Bacteriol; 1978 Jun; 44(3):Sxxxv-Sxlii. PubMed ID: 670109
    [No Abstract]   [Full Text] [Related]  

  • 40. [Formaldehyde in the preservation of cosmetic products].
    Schubert H; Köhler R; Würbach G
    Dermatol Monatsschr; 1985; 171(4):240-4. PubMed ID: 4007213
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.